Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Edwards Lifesciences (NYSE: EW) | Delayed: 90.09 +1.69 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.40 | 52 Week High | $166.87 | |||
| Open | $88.64 | 52 Week Low | $72.20 | |||
| Day High | $90.19 | P/E | 26.19 | |||
| Day Low | $88.28 | EPS | $3.44 | |||
| Volume | 3,040,448 | |||||
